Erik Berntorp
71 – 80 of 336
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Plasma-derived versus recombinant factor concentrates in PUPs : A never ending debate?
- Contribution to journal › Article
-
Mark
If you know you will also see : Population pharmacokinetics is the way to personalize and optimize prophylaxis in hemophilia
- Contribution to journal › Debate/Note/Editorial
- 2016
-
Mark
ROTEM monitoring of activated and non-activated prothrombin complex concentrate correction of dilutional coagulopathy.
- Contribution to journal › Article
-
Mark
The first Team Haemophilia Education meeting, 2015, Amsterdam, The Netherlands
- Contribution to journal › Article
-
Mark
Phenotype and genotype comparisons in carriers of haemophilia A
- Contribution to journal › Article
-
Mark
Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe
- Contribution to journal › Article
-
Mark
Patients Referred for Bleeding Symptoms of Unknown Cause : Does Evaluation of Thrombin Generation Contribute to Diagnosis?
- Contribution to journal › Article
-
Mark
Registry-based outcome assessment in haemophilia : a scoping study to explore the available evidence
- Contribution to journal › Article
-
Mark
Prophylaxis for Hemophilia in the Era of Extended Half-Life Factor VIII/Factor IX Products
- Contribution to journal › Article
-
Mark
Haemophilia treatment in 2030
- Contribution to journal › Article
